Homechevron_rightNewschevron_rightLabOnlinechevron_right$20m in financing for blood-based bowel cancer test

$20m in financing for blood-based bowel cancer test

22 March 2016

Posted in — LabOnline

Share

Venture capital firm OneVentures has closed a $19.7 million financing round for Clinical Genomics, an Australian company set to launch its next-generation blood-based diagnostic tool for colorectal cancer.

Learn More

Posted in — LabOnline

Share

chevron_leftPreviosly

Hunting for dragons: Why the second ‘valley of death’ is the biggest problem facing the Australian startup ecosystem

23 March 2016

Nextchevron_right

Clinical Genomics brings home $15M for two-gene colorectal cancer test

22 March 2016

View All

Subscribe to our Newsletter for the latest updates from 1V.

$20m in financing for blood-based bowel cancer test

Hunting for dragons: Why the second ‘valley of death’ is the biggest problem facing the Australian startup ecosystem

Clinical Genomics brings home $15M for two-gene colorectal cancer test

You may also like

Hatchtech hardly a head-scratcher for investors

$20m in financing for blood-based bowel cancer test

Vaxxas raises $25m in Series B financing

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.